PAA 3.13% 16.5¢ pharmaust limited

Not everyone is a HC member. There are sane people out there who...

  1. 1,056 Posts.
    lightbulb Created with Sketch. 2059
    Not everyone is a HC member. There are sane people out there who will view the document as 4 cent options. How many non HC shareholders out there, possibly 3000 +.

    They will possibly vote No.

    BUPO ( Board underperformance Options) is not a regular way to run a Company. No wonder the SP is like a sloth.

    I , and I hope others just want 100% Corporate Governance that's acceptable to the 99% of shareholders.

    The BOD apologists here will wallpaper any of the BOD wrongs with long inane arguments.

    What happens if it ends a NO vote does the BoD and apologists blame others who are continually trying to incorporate an air of transparency amongst our management team.

    Would a reasonable person sign a legal document which had a typo and the issuer refuses to change the typo.

    I have always wondered how the BoD were going to acquire the golden parachute upon a sale. Now everyone knows.

    Normally I would vote YES to the 15 cent options but I would vote NO if the document isn't changed.

    BUT, in conclusion the shareholders are in a Catch 22. The Company needs the cash to continue their endeavours, if we vote NO the CR situation happens again and we know the current debacle will replicate itself again and we have to go through more angst.

    My heart says NO my head says YES. Unless someone comes up with a really good argument to Vote No that will increase the SP. I am all ears !


    Kpax


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
16.5¢
Change
0.005(3.13%)
Mkt cap ! $80.22M
Open High Low Value Volume
16.5¢ 17.5¢ 16.5¢ $276.1K 1.636M

Buyers (Bids)

No. Vol. Price($)
4 379426 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.